Compugen Ltd (CGEN)
2.16
+0.01
(+0.47%)
USD |
NASDAQ |
May 07, 13:42
Compugen Cash and Short Term Investments (Quarterly): 50.68M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 50.68M |
September 30, 2023 | 57.51M |
June 30, 2023 | 66.53M |
March 31, 2023 | 74.32M |
December 31, 2022 | 83.35M |
September 30, 2022 | 88.21M |
June 30, 2022 | 96.92M |
March 31, 2022 | 106.82M |
December 31, 2021 | 117.05M |
September 30, 2021 | 102.25M |
June 30, 2021 | 110.41M |
March 31, 2021 | 119.35M |
December 31, 2020 | 123.76M |
September 30, 2020 | 132.89M |
June 30, 2020 | 136.07M |
March 31, 2020 | 121.19M |
December 31, 2019 | 43.23M |
September 30, 2019 | 47.64M |
June 30, 2019 | 36.34M |
March 31, 2019 | 38.15M |
December 31, 2018 | 45.07M |
September 30, 2018 | 34.90M |
June 30, 2018 | 42.46M |
March 31, 2018 | 20.53M |
December 31, 2017 | 29.39M |
Date | Value |
---|---|
September 30, 2017 | 38.46M |
June 30, 2017 | 45.06M |
March 31, 2017 | 54.49M |
December 31, 2016 | 60.53M |
September 30, 2016 | 68.10M |
June 30, 2016 | 73.19M |
March 31, 2016 | 81.54M |
December 31, 2015 | 80.77M |
September 30, 2015 | 75.20M |
June 30, 2015 | 96.10M |
March 31, 2015 | 66.74M |
December 31, 2014 | 73.84M |
September 30, 2014 | 108.84M |
June 30, 2014 | 115.12M |
March 31, 2014 | 120.72M |
December 31, 2013 | 51.33M |
September 30, 2013 | 47.82M |
June 30, 2013 | 32.82M |
March 31, 2013 | 29.51M |
December 31, 2012 | 24.78M |
September 30, 2012 | |
June 30, 2012 | 21.89M |
March 31, 2012 | |
December 31, 2011 | 22.37M |
September 30, 2011 |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
36.34M
Minimum
Jun 2019
136.07M
Maximum
Jun 2020
90.24M
Average
96.92M
Median
Jun 2022
Cash and Short Term Investments (Quarterly) Benchmarks
Pluri Inc | 30.62M |
BioLine Rx Ltd | 42.99M |
XTL Biopharmaceuticals Ltd | 2.006M |
Can Fite Biofarma Ltd | 8.922M |
BiomX Inc | 14.91M |